Morgan Stanley’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Morgan Stanley’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-47,139	Closed	-$472K	–	7065
2015 Q4	$472K	Buy	+47,139	New	+$522K	﹤0.01%	4588
2015 Q1	–	Sell	-9,724	Closed	-$135K	–	6983
2014 Q4	$135K	Buy	+9,724	New	+$139K	﹤0.01%	5419
2014 Q3	–	Sell	-288	Closed	-$5K	–	6946
2014 Q2	$5K	Buy	288 +279	+3,100%	+$4.78K	﹤0.01%	6307
2014 Q1	$0	Sell	9 -508	-98%	-$14.7K	﹤0.01%	6802
2013 Q4	$19K	Sell	517 -6,427	-93%	-$215K	﹤0.01%	5889
2013 Q3	$251K	Buy	6,944 +264	+4%	+$12K	﹤0.01%	4749
2013 Q2	$303K	Buy	+6,680	New	+$303K	﹤0.01%	4598

Other funds holding KBIO

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley's KBIO Position: Q1 2016 in Review

Morgan Stanley sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 47,139 shares — an estimated $472K sold.

Morgan Stanley first reported a position in KBIO in Q2 2013 and held it in 7 quarters. The position peaked at $472K in Q4 2015. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

Morgan Stanley reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
Morgan Stanley sold 47,139 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016, an estimated $472K.
Morgan Stanley first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 7 quarters.
Morgan Stanley's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $472K in Q4 2015.
1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Morgan Stanley's 13F filing for Q1 2016, filed 12 May 2016.